WelTel Support for Clinical Management of Patients

 
Printer-friendly versionSend by emailPDF version
Region: 
Africa & Middle East
Country: 
Kenya
Partners: 
University of Nairobi;
Partners/Sponsors: University of Nairobi;
University of Manitoba;
US Centers for Disease Control and Prevention (CDC);
PEPFAR Public Health Evaluation (PHE);
International Development Research Centre (IDRC);
Africa Health Systems Initiative Support to African Research Partnerships (AHSI-RES);
Activities: 

This programme operated a clinical trial in Kenya starting in 2007 that measured the effectiveness of using SMS in improving patient adherence and response to highly-active antiretroviral therapy (HAART).  The results published in 2010 found that patients who received SMS support had significantly improved ART adherence and rates of viral suppression compared with the control individuals.

Further reading: 

Lester, R.T. et al. 2010, Effects of a Mobile Phone Short Message Service on AntiretroviralTreatment Adherence in Kenya (WelTel Kenya1): A Randomised Trial, The Lancet, Vol. 376, No. 9755, pp. 1838-1845

Universities of Nairobi and Manitoba 2011, Weltel.org

Lester, R.T. et al. 2009, The HAART Cell Phone Adherence Trial (WelTel Kenya1): A Randomized Controlled Trial Protocol, Trials, vol. 10, pp. 87

[added Nov. 2010, updated Dec. 2011]

Share this

Disclaimer

The project information listed on this site does neither claim completeness, nor does the mentioning of a project present a statement regarding its status, credibility or success. While we strive to keep the content as up-to-date as possible, project information may have changed between updating cycles. Please contact us if we have missed information or corrections are required. KIT does not take responsibility or liability for projects listed on these pages, nor content of external sites that are included as links.